Identification of Clinically Approved Drugs Indacaterol and Canagliflozin for Repurposing to Treat Epidermal Growth Factor Tyrosine Kinase Inhibitor-Resistant Lung Cancer

por Li, Hongjian, Tong, Christy Wing-Sum, Leung, Yee, Wong, Man-Hon, To, Kenneth Kin-Wah, Leung, Kwong-Sak
Publicado 2017